Literature DB >> 23880345

TXNIP interacts with hEcd to increase p53 stability and activity.

Hyun-Woo Suh1, Sohyun Yun, Haeyoung Song, Haiyoung Jung, Young-Jun Park, Tae-Don Kim, Suk Ran Yoon, Inpyo Choi.   

Abstract

The p53 protein plays a central role in cell cycle arrest and apoptosis in response to diverse stress stimuli. Human ecdysoneless (hEcd) is known for its role in stabilizing the p53 protein level and increasing p53-mediated transcription. Here, we report that thioredoxin interacting protein (TXNIP), a member of the tumor suppressor family, interacts with hEcd and decreases MDM2-mediated p53 ubiquitination, leading to p53 stabilization and an increase in p53 activity. The ectopic overexpression of both TXNIP and Ecd increased actinomycin D-mediated cell death in MCF-7 cells, whereas knockdown of TXNIP and Ecd decreased cell death. These results show that TXNIP is a new regulator of the Ecd-MDM2-p53 loop.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell death; Mdm2; TRX; TXNIP; hEcd; human ecdysoneless; murine double minute-2; p53; thioredoxin; thioredoxin interacting protein

Mesh:

Substances:

Year:  2013        PMID: 23880345     DOI: 10.1016/j.bbrc.2013.07.036

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  6-Methoxyethylamino-numonafide inhibits hepatocellular carcinoma xenograft growth as a single agent and in combination with sorafenib.

Authors:  Yanning Liu; Guohua Lou; John T Norton; Chen Wang; Irawati Kandela; Shuai Tang; Nathaniel I Shank; Pankaj Gupta; Min Huang; Michael J Avram; Richard Green; Andrew Mazar; Daniel Appella; Zhi Chen; Sui Huang
Journal:  FASEB J       Date:  2017-08-17       Impact factor: 5.191

2.  A Novel Interaction of Ecdysoneless (ECD) Protein with R2TP Complex Component RUVBL1 Is Required for the Functional Role of ECD in Cell Cycle Progression.

Authors:  Riyaz A Mir; Aditya Bele; Sameer Mirza; Shashank Srivastava; Appolinaire A Olou; Shalis A Ammons; Jun Hyun Kim; Channabasavaiah B Gurumurthy; Fang Qiu; Hamid Band; Vimla Band
Journal:  Mol Cell Biol       Date:  2015-12-28       Impact factor: 4.272

3.  Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism.

Authors:  Bhopal C Mohapatra; Sameer Mirza; Aditya Bele; Channabasavaiah B Gurumurthy; Mohsin Raza; Irfana Saleem; Matthew D Storck; Aniruddha Sarkar; Sai Sundeep Kollala; Surendra K Shukla; Siddesh Southekal; Kay-Uwe Wagner; Fang Qiu; Subodh M Lele; Mansour A Alsaleem; Emad A Rakha; Chittibabu Guda; Pankaj K Singh; Robert D Cardiff; Hamid Band; Vimla Band
Journal:  Mol Cancer Res       Date:  2022-09-02       Impact factor: 6.333

4.  Dorzolamide synergizes the antitumor activity of mitomycin C against Ehrlich's carcinoma grown in mice: role of thioredoxin-interacting protein.

Authors:  Belal M Ali; Sawsan A Zaitone; Samia A Shouman; Yasser M Moustafa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-08-12       Impact factor: 3.000

5.  Proteasome inhibitor-induced cleavage of HSP90 is mediated by ROS generation and caspase 10-activation in human leukemic cells.

Authors:  Sangkyu Park; Jeong-A Park; Hwanmin Yoo; Han-Bum Park; Younghee Lee
Journal:  Redox Biol       Date:  2017-07-12       Impact factor: 11.799

6.  Mammalian ECD Protein Is a Novel Negative Regulator of the PERK Arm of the Unfolded Protein Response.

Authors:  Appolinaire A Olou; Aniruddha Sarkar; Aditya Bele; C B Gurumurthy; Riyaz A Mir; Shalis A Ammons; Sameer Mirza; Irfana Saleem; Fumihiko Urano; Hamid Band; Vimla Band
Journal:  Mol Cell Biol       Date:  2017-08-28       Impact factor: 4.272

7.  Biophysical characterization and modeling of human Ecdysoneless (ECD) protein supports a scaffolding function.

Authors:  Riyaz A Mir; Jeff Lovelace; Nicholas P Schafer; Peter D Simone; Admir Kellezi; Carol Kolar; Gaelle Spagnol; Paul L Sorgen; Hamid Band; Vimla Band; Gloria E O Borgstahl
Journal:  AIMS Biophys       Date:  2016-03-09

8.  p53 as a hub in cellular redox regulation and therapeutic target in cancer.

Authors:  Sofi E Eriksson; Sophia Ceder; Vladimir J N Bykov; Klas G Wiman
Journal:  J Mol Cell Biol       Date:  2019-04-01       Impact factor: 6.216

9.  CITED2 affects leukemic cell survival by interfering with p53 activation.

Authors:  Katharina Mattes; Gerbrig Berger; Marjan Geugien; Edo Vellenga; Hein Schepers
Journal:  Cell Death Dis       Date:  2017-10-26       Impact factor: 8.469

10.  Intracellular Cryptococcus neoformans disrupts the transcriptome profile of M1- and M2-polarized host macrophages.

Authors:  Aarthi Subramani; Prianca Griggs; Niah Frantzen; James Mendez; Jamila Tucker; Jada Murriel; Linda M Sircy; Grace E Millican; Erin E McClelland; Rebecca L Seipelt-Thiemann; David E Nelson
Journal:  PLoS One       Date:  2020-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.